110 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
, or knowingly making, or causing to be made, a false statement to get a false claim paid. The majority of states also have statutes or regulations similar … of stockholders;
requiring a majority vote of the outstanding shares of common stock to amend the bylaws; and
limiting the persons who may call special
8-K
EX-99.1
006s5v1ifgcwoqxvxa
15 Feb 24
Regulation FD Disclosure
9:15am
8-K
EX-99.1
24tu08g8qzlf88j3
24 Jan 24
Regulation FD Disclosure
8:50am
424B5
36vmuwvs1gja kfz
22 Dec 23
Prospectus supplement for primary offering
5:00pm
8-K
6sa5x3
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-4.1
4tyq8zezs4gtfmdh
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-3.1
1mbsgiu1 dnpwtf
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-10.1
qmg31xv
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-4.2
y36 a8a30opv
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-99.1
nmdbvjejk4v h88h8
18 Dec 23
Regulation FD Disclosure
8:55am
8-K
EX-99.1
88jzbld7 6caucp
20 Nov 23
Regulation FD Disclosure
9:15am
8-K
EX-99.1
ho8r e2n5a2
13 Nov 23
Regulation FD Disclosure
8:05am